Henderson, Nevada-based Digipath (OTCQB: DIGP), a testing laboratory, data and media firm focused on the cannabis and hemp markets, agreed to provide analysis and testing services to One World Pharma (OTC: OWPC), a Colombian cannabis producer.
Under the agreement, Digipath will provide analysis and testing services to One World Pharma, the company’s first commercial customer in Colombia, using compliant lab equipment and processes under ISO:17025 or similar guidelines that will meet all necessary Colombian and international standards, the company said in a statement.
One World Pharma is licensed to produce and manufacture raw cannabis and hemp plant ingredients for both medical and industrial uses in Colombia with significant approvals and Colombian relationships in place, including permission to cultivate 13 different THC strains.
Under the agreement, Digipath will establish its testing laboratory in Colombia through its newly formed Colombian subsidiary Digipath Labs SAS. It will be the exclusive testing lab for One World’s cannabis and hemp products.
Digipath plans to expand its service offerings in Colombia for One World to include soil and water testing, genetic testing, field testing, in-process and post-harvest quality assurance.
“We could not be more pleased to launch our commercial efforts in Colombia with One World Pharma,” Digipath CEO Todd Denkin stated. “We are working with a company we expect to soon be one of the leaders in the international export of clean and safe cannabis. This is a tremendous new opportunity for Digipath as we continue our efforts to become the preeminent brand in cannabis testing and quality control.”